Retinai
Bern
About Retinai
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.8M
- Funding stage: M&A
- Last round: Series B (Oct 2024)
- Website: retinai.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Cloud Computing, Health Care, Health Diagnostics, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/retinai-55955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.